» Articles » PMID: 11970907

Selective P38 Activation in Human Non-small Cell Lung Cancer

Overview
Date 2002 Apr 24
PMID 11970907
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

The mitogen-activated protein kinase (MAPK) pathways transmit signals from the cell membrane to the nucleus. Activation of MAPK cascades may play a role in malignant transformation. We hypothesized that enhanced expression of one or more of these pathways would occur in human lung cancers. Using Western blot analysis of tissue homogenates from resected non- small cell lung cancers and matched non-neoplastic lung tissue, we determined that only activated p38 was consistently increased in tumor compared with normal tissue. In vitro kinase assays confirmed that the levels of activated MAPK correlated with the activity of the enzymes, and immunohistochemical analysis confirmed the cellular localization of the activated MAPKs. We incubated a lung cancer cell line in a hypoxic chamber to simulate the hypoxic environment in solid lung tumors, but found no increase in p38 activation. Contrary to our expectations, ERK and JNK, the MAPK pathways traditionally associated with cell growth and perhaps malignant transformation, were not consistently activated in the human lung tumor samples. However, p38, a MAPK usually associated with stress responses, growth arrest, and apoptosis, was activated in all of the human lung cancer samples, suggesting an additional role for this pathway in malignant cell growth or transformation.

Citing Articles

Identification of sinensetin as a selective inhibitor for mitogen-activated protein kinase kinase 6 and an anticancer agent for non-small cell lung cancer.

Xie X, Shin Y, Kim T, Seong Y, Yi Y, Kim D Am J Cancer Res. 2025; 15(1):113-126.

PMID: 39949939 PMC: 11815360. DOI: 10.62347/RGZG2120.


Targeting ARNT attenuates chemoresistance through destabilizing p38α-MAPK signaling in glioblastoma.

Alafate W, Lv G, Zheng J, Cai H, Wu W, Yang Y Cell Death Dis. 2024; 15(5):366.

PMID: 38806469 PMC: 11133443. DOI: 10.1038/s41419-024-06735-1.


Suppressing MTERF3 inhibits proliferation of human hepatocellular carcinoma via ROS-mediated p38 MAPK activation.

Zheng Z, Zhao Y, Yu H, Wang T, Li J, Xu L Commun Biol. 2024; 7(1):18.

PMID: 38177713 PMC: 10767110. DOI: 10.1038/s42003-023-05664-7.


Licochalcone A induces cell cycle arrest and apoptosis via suppressing MAPK signaling pathway and the expression of FBXO5 in lung squamous cell cancer.

Fan X, Guan G, Wang J, Jin M, Wang L, Duan X Oncol Rep. 2023; 50(6).

PMID: 37859622 PMC: 10620845. DOI: 10.3892/or.2023.8651.


Tumor Promoting Function of DUSP10 in Non-Small Cell Lung Cancer Is Associated With Tumor-Promoting Cytokines.

Wei X, Png C, Weerasooriya M, Li H, Zhu C, Chen G Immune Netw. 2023; 23(4):e34.

PMID: 37670811 PMC: 10475826. DOI: 10.4110/in.2023.23.e34.